Antiangiogenic therapy using nanotechnological-based delivery system.

Kanwar, Jagat R; Mahidhara, Ganesh; Kanwar, Rupinder K

Kanwar, Jagat R; Mahidhara, Ganesh; Kanwar, Rupinder K.

Affiliation

Kanwar JR; Laboratory of Immunology and Molecular Biomedical Research (LIMBR), Centre for Biotechnology and Interdisciplinary Biosciences (BioDeakin), Institute for Technology Research and Innovation (ITRI), Deakin University, Waurn Ponds, VIC 3217, Australia. jagat.kanwar@deakin.edu.au

Drug Discov Today ; 16(5-6): 188-202, 2011 Mar.

Article in En | MEDLINE | ID: mdl-21262383

Subject(s)

Angiogenesis Inhibitors/pharmacology; Antineoplastic Agents/pharmacology; Neoplasms/drug therapy; Animals; Apoptosis/drug effects; Drug Delivery Systems; Humans; Nanoparticles; Nanotechnology/methods; Neoplasms/blood supply; Neoplastic Stem Cells; RNA/administration & dosage

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Angiogenesis Inhibitors / Neoplasms / Antineoplastic Agents Limits: Animals / Humans Language: En Year: 2011 Type: Article

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Angiogenesis Inhibitors / Neoplasms / Antineoplastic Agents Limits: Animals / Humans Language: En Year: 2011 Type: Article